Growth Update - Turner Syndrome Practice Updates

Speciality: Physician (Internal Medicine)


Speaker:

Dr. Ahila Ayyavoo - Moderator | DCH, DNB (Paed), PhD Consultant, Paediatric Endocrinologist

Dr. Soundaram V - Speaker | Consultant Paediatric Endocrinologist,

Dr. Shobi Anandi V - Speaker | MD (Ped); DNB (Ped); Fellowship in Pediatric and Adolescent Endocrinology, Consultant Pediatric Endocrinologist

Description:

A warm welcome to all the medical professionals in this interesting session on Growth Update - Turner Syndrome Practice Updates
Turner Syndrome (TS) is a chromosomal disorder affecting females, characterized by partial or complete loss of one X chromosome. Recent practice updates emphasize the importance of early diagnosis and intervention to optimize growth and development outcomes. Growth hormone (GH) therapy has become a cornerstone in managing short stature associated with TS, with evidence showing significant improvements in height when initiated at an early age. Regular monitoring and individualized dosing are critical to maximize the benefits of GH therapy while minimizing potential side effects.
Advancements in genetic testing have improved the accuracy and speed of diagnosing Turner Syndrome, allowing for earlier and more precise interventions. These updates also highlight the importance of a multidisciplinary approach in managing TS, addressing not only growth concerns but also associated comorbidities such as cardiovascular, renal, and reproductive health issues. Comprehensive care plans involving endocrinologists, cardiologists, nephrologists, and reproductive specialists are essential to provide holistic care for individuals with TS.
Therefore, get an overall knowledge of Growth Update - Turner Syndrome Practice Updates
 

See More Webinars @ Hidoc Webinars




Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Chemo-Free Regimen for Ph+ ALL Yields High Rate of Deep MRD Negativity

2.

Novel Treatment Shows Promise for Oral Mucositis Caused by Radiation.

3.

Cancer diagnosis does not spur improvements to survivors' diets or eating habits

4.

Innovative oncology therapeutics are being created in collaboration between Moderna and Immatics.

5.

Microplastics can cause malignant changes in lung cells


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot